Mark E. Lasbury
Mark E. Lasbury publishes mostly in Epidemiology, Infectious Diseases and Organic Chemistry, on topics such as Pneumocystis jirovecii pneumonia detection and treatment, Pneumonia and Respiratory Infections and Tuberculosis Research and Epidemiology.
- World rank
- #7,210,429 of 7,710,434 ranked researchers
- Rank in United States
- #1,592,250 of 1,627,098
- Works
- 61
- Citations
- 670
- Citations per work
- 11.0
What does Mark E. Lasbury research?
Mark E. Lasbury's work is mostly in Medicine (54%), Chemistry (7%), Biochemistry, Genetics and Molecular Biology (7%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences3354.2%
- Medicine3354.2%
- Everything else1727.4%
- Physical Sciences711.7%
- Chemistry47.3%
- Computer Science12.2%
- Physics and Astronomy12.2%
- Life Sciences46.7%
- 1Epidemiology36% of their works
- 2Infectious Diseases18% of their works
- 3Organic Chemistry7% of their works
- 4Molecular Biology7% of their works
- 5Artificial Intelligence2% of their works
- 6Astronomy and Astrophysics2% of their works
Research topics
- Pneumocystis jirovecii pneumonia detection and treatment
- Pneumonia and Respiratory Infections
- Tuberculosis Research and Epidemiology
- HIV/AIDS drug development and treatment
- Synthesis and Biological Evaluation
- Polyamine Metabolism and Applications
- Adenosine and Purinergic Signaling
- Peptidase Inhibition and Analysis
Which keywords describe Mark E. Lasbury's research?
The keywords of their largest research topics: Epidemiology, Diagnosis, Treatment, Antiretroviral Therapy, Pneumocystis, Pneumonia, Drug Resistance and Community-Acquired Pneumonia.
- Purinergic Signalling
- Fibroblast Activation Protein
- Polyamines
- Tumor Microenvironment
- Quinoxaline
- HIV Infection
- Pneumococcal Conjugate Vaccine
- Community-Acquired Pneumonia
- Pneumonia
- Antiretroviral Therapy
- Diagnosis
- Epidemiology
- Treatment
- Pneumocystis
- Drug Resistance
- Mycobacterium tuberculosis
- Tuberculosis
- Integrase Inhibitors
- Synthesis
- Biogenic Amines
- Adenosine Receptors
- Immunosuppression
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 22 words, with their numbers
- Epidemiology853 topics
- Diagnosis652 topics
- Treatment652 topics
- Antiretroviral Therapy572 topics
- Pneumocystis451 topic
- Pneumonia451 topic
- Drug Resistance322 topics
- Community-Acquired Pneumonia201 topic
- Mycobacterium tuberculosis201 topic
- Pneumococcal Conjugate Vaccine201 topic
- Tuberculosis201 topic
- HIV Infection121 topic
- Integrase Inhibitors121 topic
- Quinoxaline101 topic
- Synthesis101 topic
- Tumor Microenvironment62 topics
- Biogenic Amines41 topic
- Polyamines41 topic
- Adenosine Receptors31 topic
- Fibroblast Activation Protein31 topic
- Immunosuppression31 topic
- Purinergic Signalling31 topic
Where does Mark E. Lasbury work?
Mark E. Lasbury's main affiliation in the publication record is Indiana University – Purdue University Indianapolis, United States.
How many publications and citations does Mark E. Lasbury have?
OpenAlex counts 61 works and 670 citations for Mark E. Lasbury, an h-index of 14, ranking #7,210,429 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Mark E. Lasbury. Posts are plain text and can be reported.